Euan Haynes, MBBS^1*, Kushani Ediriwickrema, MBBS, BSc, MRCPI^2,3*, Sarah Lawless, BSc, FRCPath, MRCP^4*, Kevin Joyce^5*, Matthew Wells^6*, Jeffrey Smith^5*, Kim Linton^7*, Anna Santarsieri, MBBS^8*, George Follows, MA, BM, BCh, PhD, FRCP, FRCPath^8*, John Willan, BMBS^9*, Robert Osborn^10*, Matthew R Wilson^11*, Pamela McKay, MBChB (Hons), FRCP, FRCPath^10*, Mahina Baloch, MBBS^12*, Rory McCulloch, FRCPath, MRCP, MBBS^12*, Mary Gleeson^13*, David Wrench^13,14*, David Foldes, MBBS^15*, Edward Kanfer^15*, Kyaw Zin Maw, FRCPath^16*, Andrea Kuhnl^17*, Matthew Ahearne^18*, Mary Owen^19*, Jane Norman^20*, Ravindu De Silva, MBBS^21*, Nimish Shah^22*, Harriet Ambrose^23*, Christopher P. Fox, MBChB(Hons), PhD, FRCP²⁴, Janine Qasim^25*, Graham P. Collins²⁵, Martha Vickers^26*, David Tucker²⁷, Li Yuan Chan^28*, Sunil Iyengar²⁹, Dima el-Sharkawi^29*, Rebecca Auer, MD, PhD^30*, Catherine Cox^31*, Hwai Jing Hiew, MD, FRCPath^32*, Andrew J. Davies, MD, PhD^32*, Philippa Kelsey, MBChB MRCP FRCPath^33*, David John Lewis, MD^34*, Abigail Martin^34*, Gavin Preston, PhD, MBBS, FRCP, FRCPath^35*, Dominic J. Culligan, MD, FRCP, FRCPath, BSc, MBBS^35*, Angus Broom^36*, William Wilson, PhD^37*, Wendy Osborne, MD^38,39* and William Townsend^40*

¹Newcastle-Upon-Tyne NHS Foundation Trust, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
²University College London Hospitals NHS Foundation Trust, London, GBR
³University College London, CRUK and UCL Cancer Trials Centre, London, United Kingdom
⁴Belfast Health and Social Care Trust, Belfast City Hospital, Belfast, GBR
⁵Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
⁶Clatterbridge Cancer Centre NHS Foundation Trust,, Liverpool, United Kingdom
⁷The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
⁸Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom
⁹Frimley Park Hospital, Frimley Health NHS Foundation Trust, Surrey, United Kingdom
¹⁰Beatson West of Scotland Cancer Centre, Greater Glasgow and Clyde NHS Foundation Trust, Glasgow, United Kingdom
¹¹Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹²Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom
¹³Guys Hospital, Guys and St Thomas' NHS Trust, London, United Kingdom
¹⁴Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
¹⁵Imperial College Healthcare NHS Trust, London, United Kingdom
¹⁶James Paget University Hospital NHS Foundation Trust, Norfolk, United Kingdom
¹⁷King's College Hospital NHS Foundation Trust, London, United Kingdom
¹⁸University Hospitals Leicester NHS Trust, Leicester, United Kingdom
¹⁹Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
²⁰Manchester Royal Infirmary, Manchester, United Kingdom
²¹Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk, United Kingdom
²²Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom
²³Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
²⁴School of Medicine, University of Nottingham, Nottingham, United Kingdom
²⁵Oxford University Hospitals, Oxford, United Kingdom
²⁶Royal Cornwall Hospital NHS Trust, Cornwall, United Kingdom
²⁷Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
²⁸Royal Marsden NHS Foundation Trust, London, United Kingdom
²⁹The Royal Marsden NHS Foundation Trust, London, United Kingdom
³⁰Barts Health NHS Trust, London, United Kingdom
³¹St. George's University Hospitals NHS Foundation Trust, London, United Kingdom
³²University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
³³Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
³⁴University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
³⁵Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
³⁶Western General Hospital, NHS Lothian, Edinburgh, United Kingdom
³⁷Cancer Research UK & UCL Cancer Trials Centre, University College London Cancer Institute, London, United Kingdom
³⁸Consultant Haematologist, Honorary Clinical Senior Lecturer, Newcastle Hospitals – Newcastle University, Newcastle Upon Tyne, United Kingdom
³⁹Newcastle University, Newcastle, United Kingdom
⁴⁰University College Hospital London, London, United Kingdom

Christopher Yasenchak, MD¹, Nancy L. Bartlett, MD², Jeong-A Kim³, Uwe Hahn^4*, Craig A. Portell^5*, Francesco Zaja^6*, Thorsten Zenz⁷, Cecily Forsyth, MD⁸, Jin Seok Kim, MD, PhD^9*, Seok-Goo Cho^10*, Jae-Yong Kwak¹¹, Hao-Yuan Wang, MD¹², Herve Ghesquieres, MD, PhD^13*, Grzegorz S. Nowakowski, MD¹⁴, Monica Patterson^15*, Linda Ho^15*, Evelyn Rustia^15*, Michelle Fanale^16*, Keenan Fenton^15* and Frank Stenner^17*

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
²Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
³St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
⁴Royal Adelaide Hospital, Adelaide, Australia
⁵UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA
⁶Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
⁷University Hospital of Zürich, Zurich, Switzerland
⁸Central Coast Local Health District (Gosford and Wyong Hospitals), Gosford, Australia
⁹Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
¹⁰Seoul Saint Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹¹Jeonbuk National University Hospital, Jeonju, Korea, Republic of (South)
¹²Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
¹³Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
¹⁴Mayo Clinic, Rochester, MN
¹⁵Pfizer Inc., Bothell, WA
¹⁶Pfizer, New York, NY
¹⁷University Hospital of Basel, Basel, Switzerland

Tae Min Kim, MD, PhD^1,2*, Jung Sun Kim, MD^1,2*, Gyeong-Won Lee, MD^3*, Myung-Won Lee, MD⁴, Jeonghwan Youk, MD^1,2*, Hyun Jung Lee, MD^5*, Sung-Nam Lim, MD^6*, Soyeon Kim, PhD^2,7*, Yoon Kyung Jeon, MD, PhD⁸, Chul-Kee Park, MD^9* and Dae Seog Heo, MD, PhD^1,2*

¹Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Seoul National University Cancer Research Institute, Seoul, Korea, Republic of (South)
³Gyeongsang National University Hospital School of Medicine Gyeongsang National U, Jinju, Korea, Republic of (South)
⁴Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
⁵Kyung Hee University Hospital, Seoul, Korea, Republic of (South)
⁶Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
⁷Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
⁸Seoul National University Collge of Medicine, Seoul, KOR
⁹Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea, Republic of (South)

Mingyuan Sun, MD^1*, Lugui Qiu, MD¹, Keshu Zhou, MD^2*, Kai Hu, MD³, Chunkang Chang, MD^4*, Dong Wu, MD^5*, Zhenling Li^6*, Ming Gong, MM^6*, Wenjun Zhang, PHD^7*, Daniel Yang, MD^7*, Jiali Lu, MD^7* and Junyuan Qi, MD^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Beijing GoBroad Boren Hospital, Beijing, China
⁴Hematology department, Shanghai Sixth People's Hospital, Shanghai Jiaotong University school of Medicine, Shanghai, China
⁵Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
⁶China-Japan Friendship Hospital, Beijing, China
⁷ExcelMab Inc., Guangzhou, China

Soraya Carrancio, PhD^1*, Jessica Voetsch, PhD^2*, Alberto Risueño, PhD^3*, Carla Guarinos^4*, Siddhesh Kulkarni^5*, Mandeep Takhar^6*, Matthew E. Stokes^5*, Bérengère de Moucheron, PharmD^4*, Laura Furman^7*, Julio C. Chavez, MD⁸, Jean-Marie Michot^9*, Loretta Nastoupil^10*, Daniel W. Pierce^11*, Danielle Greenawalt^12* and Michael Pourdehnad, MD¹³

¹Oncogenesis (ONC) Thematic Research Center (TRC), Bristol Myers Squibb, San Diego, CA
²Translational Informatics and Predictive Sciences, Bristol Myers Squibb, Lawrence Township, NJ
³Bristol Myers Squibb, Lawrenceville, NJ
⁴Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
⁵Bristol Myers Squibb, Summit, NJ
⁶Bristol-Myers Squibb, Seattle, WA
⁷Bristol Myers Squibb, Princeton, NJ
⁸Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL
⁹Gustave Roussy Cancer Campus, Villejuif, France
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Research and Development, Bristol Myers Squibb, Brisbane, CA
¹²Bristol Myers Squibb, Lawrence Township, NJ
¹³Bristol Myers Squibb, Brisbane, CA

Iman Ahmed, PharmD^1*, Victoria Nachar, PharmD^1*, Lydia Benitez, PharmD², Shannon A. Carty, MD¹, Dahlia Sano, MBCHB¹, Ryan A. Wilcox, MD, PhD¹, XI Yang, MD¹, Jonathan Weiss, MD¹ and Yasmin H. Karimi, MD¹

¹Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
²University of Michigan College of Pharmacy, Michigan Medicine, Ann Arbor, MI

Lori A. Leslie, MD^1*, Chan Y. Cheah, MBBS, DMSc^2*, Franck Morschhauser, MD, PhD³, Justin M. Darrah, MD^4*, Joshua Brody, MD^5*, David Belada, MD, PhD⁶, Juraj Duras, MD^7*, Joost S.P. Vermaat⁸, Gerardo Musuraca, MD, PhD^9*, Kojo Osei-Bonsu, MD^10*, Yi Hao, DrPH^11*, Kimberly G. Archer^11*, Monica Wielgos-Bonvallet, PhD^11*, Ali Rana, MD, PhD^11* and Yasmin H. Karimi, MD¹²

¹John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
²Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia
³University of Lille, CHU Lille, Lille, France
⁴Division of Hematology and Cellular Therapy, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
⁵Icahn School of Medicine at Mount Sinai, New York, NY
⁶4th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
⁷Department of Hemato-Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic
⁸Leiden University Medical Center, Leiden, Netherlands
⁹Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori", Meldola, Italy
¹⁰AbbVie, North Chicago, IL
¹¹Genmab, Plainsboro, NJ
¹²Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

Changgon Kim, MD, PhD^1*, SangEun Yoon, MD, PhD^2*, Hyun-Young Kim, MD^3*, Duck Cho^4*, Hong Hoe Koo, MD., PhD^5*, Junhun Cho, MD., PhD^6*, Won Seog Kim, MD^7* and Seok Jin Kim, MD, PhD⁸

¹Samsung Medical Center, Seoul, Korea, Republic of (South)
²Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
³Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Jinju, Korea, Republic of (South)
⁴Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁵Sungkyunkwan Univ., School of Med. Samsung Medical Ctr., Seoul, KOR
⁶Department of Pathology and Translational Genomics, Samsung Medical Center, SEOUL, KOR
⁷Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁸Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Charlotte Rigaud, MD^1*, Kim P.J. Schellekens^2,3*, Christine Damm-Welk^4*, Veronique Minard-Colin^5*, Samuel D. Abbou^5*, Gertruud Bakker^2*, Auke Beishuizen, MD⁶, Maaike Boonstra-Schelfhorst^2*, Laurence Brugières^5*, Michela Casanova^7*, Pascal Chastagner^8*, Rana Dandis^2*, Stéphane Ducassou^9*, Natasha K.A. van Eijkelenburg^2*, Nathalie Garnier^10*, Michael J. Hanley^11*, Alwin D.R. Huitema^2,12,13*, Samantha Lampron^11*, Yousif H. Matloub¹¹, Nicole Scobie^14*, Florin Vranceanu^11*, Jen-Hao Wu^2*, Wilhelm Woessmann^4*, C. Michel Zwaan^2,3 and Reineke A. Schoot^2*

¹Pediatric Hematology Department, Gustave Roussy, Villejuif, France
²Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
³Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
⁴University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁵Gustave Roussy Cancer Campus, Villejuif, France
⁶Princess Máxima Centre, Utrecht, Netherlands
⁷Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁸Hopital D'Enfants, CHU Nancy, Vandoeuvre, France
⁹CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France
¹⁰IHOPE Lyon, Lyon, France
¹¹Takeda Development Center Americas, Lexington, MA
¹²Netherlands Cancer Institute, Amsterdam, Netherlands
¹³University Medical Center Utrecht, Utrecht, Netherlands
¹⁴Zoé4Life, Sullens, Switzerland

Mariana Bastos-Oreiro^1*, Gloria Iacoboni, MD^2*, Víctor Navarro Garces^3*, Hugo Daniel Luzardo Henríquez^4*, Maria Jose Rodriguez Salazar^5*, Paula Fernández Caldas-González^6*, Paula Fernández Caldas-González^6*, Irene Medina^7*, Pablo Manresa^8*, Sonia González De Villambrosia^9*, Antonio Gutierrez, MD, PhD^10*, Eva Donato^11*, Maria Teresa Busnego Barreto^12*, Norma C. Gutierrez^13,14*, Javier López^15*, Fernando Martín Moro^16*, Ana García-Noblejas^17*, Pilar Gómez^18*, Samuel Romero, MD^19*, Ana Jiménez Ubieto^20*, Elena Perez Ceballos^21*, Belen Navarro^22*, Lucia Villalon Blanco^23*, María Angeles Goñi Herranz^24*, Miguel Ángel Rodríguez Gil^25*, Victoria Dourdil^26*, Irati Ormazabal Vélez^27*, Piva Sanchez Anton^28*, Ramon Garcia-Sanz, MD, PhD^29,30, Pau Abrisqueta Costa^31* and Alejandro Martín García-Sancho^32*

¹Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
²Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, SEATTLE, WA
³Oncology Data Science (odyssey) Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Barcelona, Spain
⁴Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
⁵Hematology, Hospital Universitario de Tenerife, La Laguna, ESP
⁶Hematology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
⁷Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain, BARCELONA, Spain
⁸Hospital Universitario Dr. Balmis, ALICANTE, Spain
⁹Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁰Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
¹¹Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
¹²Hospital Universitario de la Candelaria, Santa Cruz De Tenerife, ESP
¹³Hospital Universitario De Salamanca, IBSAL, Salamanca, Spain
¹⁴Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
¹⁵Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁶Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁷Hospital Universitario de La Princesa, Madrid, Spain
¹⁸Hospital La Paz, Madrid, Spain
¹⁹Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
²⁰Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
²¹Hospital Universitario Morales Meseguer, MURCIA, ESP
²²Hospital Puerta De Hierro, Madrid, ESP
²³Hospital Universitario Fundación Alcorcón, Alcorc N, Madrid, ESP
²⁴Complejo Hospitalario de Navarra, Pamplona, Spain
²⁵Hospital Universitario Virgen de las Nieves, Granada, Spain
²⁶Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
²⁷Hospital Universitario de Navarra, Pamplona, Spain
²⁸Hospital Universitario de Navarra, Pamplona, ESP
²⁹General University Hospital Gregorio Marañón, Madrid, Spain
³⁰Health Research Institute Gregorio Marañón, Madrid, Spain
³¹University Hospital Vall d’Hebron, Barcelona, Spain
³²Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain

Ronit Gurion^1*, Irit Avivi Mazza^2*, Catherine Thieblemont, MD³, Won Seog Kim^4*, Andras Masszi, MD, PhD^5*, Alejandro Martín García-Sancho^6*, Zsolt Nagy, MD, PhD^7*, Benoit Tessoulin, MD, PhD^8*, Ana Jimenez Ubieto^9*, Po-Shen Ko, MD^10*, Daniel Alan Kerr II, MD, PhD^11*, Edwin E. Jeng, PhD^12*, Satya Siddani, PhD^12*, Neha Joshi, PhD^12*, Neha Dixit, PhD¹³, Mariana Sacchi, MD^14*, Pegah Jafarinasabian, MD, PhD^12* and Abraham Avigdor, MD¹⁵

¹Rabin Medical Center, Petah Tikva, and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Hematology Division, Sourasky Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France
⁴Samsung Medical Center, Seoul, Korea, Republic of (South)
⁵Orszagos Onkologiai Intezet, Budapest, Hungary
⁶Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain
⁷Semmelweis Egyetem, Budapest, Hungary
⁸CHU de Nantes, Hotel Dieu, Paris, France
⁹Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁰Taipei Veterans General Hospital Division of Hematology, Taipei, TWN
¹¹Tampa General Hospital, Tampa, FL
¹²AbbVie Inc, North Chicago, IL
¹³AbbVie Inc, South San Francisco, CA
¹⁴Genmab, Plainsboro, NJ
¹⁵Sheba Medical Center, Ramat Gan, Israel

Neil Bailey, MSc¹, Tori Braun^1*, Megumi Bailey^2*, Tenzin Tsomo, BS^1*, Jennie Szeto, BA^1*, Swathi Namburi¹, Joanna Fesler, ARNP^2*, Sonia Glennie, ARNP^2*, Vanessa Dunleavy, ARNP^2*, Julia Carolyn Bokma Parker, ARNP^2*, Gayle Funk, PA-C^2*, Heidi Hohmann, RN^2*, Chiachun Lu^2*, Jordan Briggs, BSN^1* and Krish Patel, MD²

¹Swedish Cancer Institute, Seattle, WA
²Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA

Jennifer E. Amengual, MD¹, Aung M. Tun², Ted B. Piorczynski, PhD³, Yun Kyoung Tiger, MD, PhD⁴, Victor Yazbeck, MD⁵, Hua-Jay J Cherng, MD⁶, Seda S. Tolu, MD⁷, Barbara Pro, MD⁸, Diane Durecki, MS^9*, Jan Beumer, PhD^10*, Neil Kelleher^11*, Naomi Sender^12*, Sarah Sta Ana^12*, Anxhela Kalia^13*, Beatriz Raposo Corradini^12*, Yu Shyr^14*, Patricia LoRusso^15*, Lorraine Pelosof, MD, PhD^16* and Richard Piekarz, MD, PhD^17*

¹Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
³Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY
⁴Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁵VCU Massey Cancer Center, Richmond, VA
⁶Division of Hematology & Oncology, Columbia University Irving Medical Center, Long Island City, NY
⁷Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY
⁸Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁹Yale Cancer Center, New Haven
¹⁰University of Pittsburgh Hillman Cancer Center, Pittsburgh
¹¹Northwestern University, Evanston, IL
¹²Columbia University, New York, NY
¹³Columbia University, New York
¹⁴Virginia Commonwealth University, Nashville
¹⁵Yale Cancer Center, New Haven, CT
¹⁶Investigational Drug Branch, CTEP, National Institutes of Health, Silver Spring, MD
¹⁷Division of Cancer Research, National Cancer Institute, Rockville, MD

Tao You, M.D., PhD^1,2*, Jingxian Gu, M.D.^1,2*, Peng Xu, M.D.^3*, Jiebing Xiao, M.D.^3*, Huiru Cao, M.D.^3*, Wei Dai, M.D.^3*, Jie Bai, M.D.^3*, Peng Wang, M.D.^3*, Xiao Ma^1,2*, Depei Wu, MD, PhD^1,2 and Haiwen Huang, MD^1,2*

¹Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
³Soochow Hopes Hematonosis Hospital, Suzhou, China

Silvia Ferrari, MD^1*, Anna Maria Barbui, MD^2*, Gritti Giuseppe^3*, Andrea Rossi, MD^4*, Anna Grassi^5*, Francesco Ballardini^6*, Monica Rondi^4*, Chiara Pavoni^5*, Paolo Fruscella^7*, Andrea Gianatti^8* and Alessandro Rambaldi^5,9

¹Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Santa Monica, CA
²Department of Oncology and Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
³Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Verdello, BG, ITA
⁴Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁵Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁶Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁷Department of Pathological Anatomy, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁸Department of Pathological Anatomy, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, ITA
⁹Department of Oncology and Hematology, University of Milan, Milan, Italy

Tycel J. Phillips, MD¹, Michael Roost Clausen, MD, PhD^2*, Wojciech Jurczak, MD, PhD³, Tae Min Kim, MD, PhD^4*, Kim Linton^5*, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc⁶, Jieying Jiang^7*, Kubra Karagoz, PhD, MSc^8*, Mohammad Atiya, PharmD^9*, Christian Eskelund, MD, PhD^8*, Han Si, PhD^8*, Edith Szafer Glusman, PhD^10*, Andrew J. Steele, PhD^8*, Charles Kearns, PhD^10* and Catherine Thieblemont, MD¹¹

¹City of Hope, Pasadena, CA
²Vejle Hospital, Vejle, Denmark
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
⁴Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
⁶Department of Haematology, Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia
⁷AbbVie Inc., North Chicago, IL
⁸Genmab, Plainsboro, NJ
⁹Genmab US Inc, Plainsboro, NJ
¹⁰AbbVie Inc, North Chicago, IL
¹¹Hospital Saint-Louis, Paris, France

Jia Jin^1,2, Yalan Wang^3*, Xi Wang^3*, Yonghong Tang^4*, Shan Zeng^4*, Juan Du, MD, PhD⁵ and Junning Cao^1,2

¹Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
²Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
³Department of Lymphoma, Baotou Tumor Hospital, Baotou, Inner Mongolia, China
⁴Department of Internal Oncology, Xiangya Hospital of Central South University, Changsha, Hunan, China
⁵Department of Lymphoma, Shanghai Changzheng Hospital, Shanghai, China

Federica Colombo, MD^1,2*, Andrea Aroldi, MD^1*, Stefano Crippa, MD^1,2*, Federica Cocito, MD^1*, Luca Guerra, MD, Prof.^2,3*, Lavinia Monaco, MD^3*, Bianca Maria Granelli, MD^1,2*, Lara Mussolin, PhD^4* and Carlo Gambacorti-Passerini, MD, Prof.^1,2

¹Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
²Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
³Nuclear Medicine Division, IRCCS San Gerardo dei Tintori, Monza, Italy
⁴Pediatric Hematology-Oncology, University of Padua, Padua, Italy

John N. Allan, MD¹, Jennifer L. Crombie, MD², Matthew Matasar, MD, MS³, Max S. Topp^4*, Jan Walewski^5*, Tae Min Kim, MD, PhD^6*, Won-Seog Kim^7*, Yuan Cheng^8*, Dina Flink⁸, Bertha Fearon Chalet^8*, Hesham Mohamed⁸, Srikanth Ambati⁸, Aafia Chaudhry⁸ and Jon E. Arnason, MD⁹

¹Weill Cornell Medicine, New York, NY
²Dana-Farber Cancer Institute, Boston, MA
³Division of Blood Disorders, Rutgers Cancer Institute and RWJBarnabas Health, New Brunswick, NJ
⁴Universitätsklinikum Würzburg, Würzburg, Germany
⁵Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland
⁶Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
⁸Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁹Beth Israel Deaconess Medical Center, Boston, MA

Yuqin Song, MD¹, Qingqing Cai, PhD², Keshu Zhou, MD^3*, Ming Jiang^4*, Zhengming Jin, M.D.^5*, Lei Zhang, PhD, MD^6*, Xiuhua Sun^7*, Haiyan Yang^8*, Lanfang Li^9*, Kaiyang Ding^10*, Junyuan Qi, MD^11*, Hongmei Jing^12*, Wei Yang^13*, Min Zhou^14*, Jun Ma^15*, Zhigang Peng^16*, Wei Xu^17*, Hui Zhou, MD¹⁸, Li Yu^19*, Yuankai Shi, MD^20*, Guohui Cui^21*, Zheng Wang^22*, Nawei Liu^22*, Yejiang Lou, PhD^23*, Yue Shen, PhD^22*, Yi Chen, PhD^24*, Fenlai Tan^22* and Jun Zhu, MD^25*

¹Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
³Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China
⁵Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁶The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
⁷The Second Hospital of Dalian Medical University, Dalian, China
⁸Zhejiang Cancer Hospital, Hangzhou, China
⁹Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹⁰Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
¹¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
¹²Department of Hematology, Peking University Third Hospital, Beijing, China
¹³Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
¹⁴Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
¹⁵Harbin Institute of Hematology & Oncology, Harbin, China
¹⁶The First Affiliated Hospital of Guangxi Medical University, Nanning, China
¹⁷Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
¹⁸Department of Lymphoma & Hematology, Hunan Cancer Hospital and Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
¹⁹The Second Affiliated Hospital of Nanchang University, Nanchang, China
²⁰Cancer Hospital (Institute), CAMS & PUMC, Beijing, China
²¹Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²²Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
²³Guangzhou Lupeng Pharmaceutical Co., Ltd., Hangzhou, China
²⁴Newave Pharmaceutical Inc., Pleasanton, CA
²⁵Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Minis-try of Education), Peking University Cancer Hospital & Institute, Beijing, China

Sung-Soo Yoon, M.D., Ph.D.¹, Zhiming Li, PhD, MD², Seokjin Kim^3*, Ki-Seong Eom, MD, PhD^4*, Keshu Zhou^5*, Sung-Nam Lim, MD^6*, Xiaoxi Zhou^7*, Ye Guo^8*, Sung Yong Oh^9*, Huilai Zhang, MD¹⁰, Hagop Youssoufian, MD^11*, Vernon Jiang, PhD¹¹, Zanchun Huang^12*, Georgina Kilfoil^12*, Xin Wang^11*, Zhixiang Cao^11*, Xiang LI^11*, Yihai Lin^12*, Alexander Wu, Ph.D.^12*, Yiyou Chen, Ph.D.^11* and Yuqin Song, MD¹³

¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
³Samsung Medical Center, Seoul, KOR
⁴Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
⁶Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
⁷Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁸Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
⁹Dong-A University Hospital, Busan, Korea, Republic of (South)
¹⁰Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
¹¹Cothera Bioscience, San Mateo, CA
¹²Cothera Bioscience, San Mateo,, CA
¹³Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China

Xiaolei Wei, MD^1*, Xutao Guo, MD^2*, Qi Wei, MD^3*, Yongqiang Wei, MD^1* and Ru Feng^4*

¹Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
²Nanfang Hospital, GUANGZHOU, GUANGDONG, China
³Guangzhou Dadao North Street NO. 1838, Guangzhou, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangzhou, China
⁴Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China, Guangdong, China

Mark Roschewski, MD¹, Christopher Melani, MD², Rahul Lakhotia, MBBS¹, Tatyana Gavrilova, MD^3*, Jagan R. Muppidi, MD, PhD^4*, James D. Phelan, PhD^1*, Michail S. Lionakis, MD, ScD^5*, Kieron Dunleavy, MD⁶, Lode J. Swinnen, MBCHB⁷, Matthias Holdhoff, MD^8*, Catherine E. Lai, MD⁹, Sami Ibrahimi, MD¹⁰, Michael Glantz, MD, PhD^11*, Jan Drappatz, MD^12*, John A. Butman, MD, PhD^13*, Stefania Pittaluga, MD, PhD^14*, Kim Johnson, RN^1*, Candis Morrison, NP, PhD^1*, Nick Micheletti, MS^15*, John D. Heiss, MD^16*, William D. Figg, PharmD^17*, Elaine S. Jaffe, MD¹⁸, S. Percy Ivy, MD^19*, Richard F. Little, MD, MPH²⁰, Louis M. Staudt, MD, PhD²¹ and Wyndham H. Wilson, MD, PhD^1*

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Derwood, MD
³Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
⁴Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
⁵Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁶Georgetown University, Washington, DC
⁷Johns Hopkins Cancer Center, Baltimore, MD
⁸Department of Neuro-Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
⁹Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
¹⁰OU Health Stephenson Cancer Center, Oklahoma City
¹¹Department of Neurosurgery and Oncology, Penn State College of Medicine, Hershey Medical Center, Hershey, PA
¹²Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA
¹³Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD
¹⁴Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁵Office of Collaborative Biostatistics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁶Surgical Neurology Branch, National Institute of Neurologic Disorders and Stroke, Bethesda
¹⁷Molecular Pharmacology Section, Genitourinary Malignancies Section, Center for Cancer Research, National Cancer Institute,, National Institutes of Health, Bethesda, MD
¹⁸Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Great Falls, VA
¹⁹National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
²⁰National Cancer Institute, National Institutes of Health, Bethesda, MD
²¹Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Michael J. Dickinson, MBBS, DMedSci¹, Martin Hutchings, MD, PhD², Franck Morschhauser, MD, PhD³, Carmelo Carlo-Stella, MD⁴, Lorenzo Falchi, MD⁵, Paolo F. Caimi, MD⁶, Natalie Dimier, PhD^7*, Lance Smith^8*, Matt Whayman^8*, Johannes Sam, PhD^9*, Abiraj Keelara, PhD^10*, Koorosh Korfi, PhD¹¹, Candice Jamois, PharmD^12*, Jeremy Gallien^10*, Nicole Martin^11*, Iris Martinez Quetglas^11*, Heather Hinton^13*, Isabel Prieto^14*, Francesca Michielin^15*, Katharina Lechner^16* and Giuseppe Gritti, MD, PhD^17*

¹Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, VIC, Australia
²Department of Hematology and Phase 1 Unit, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
³Department of Hematology and GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, University Lille, Lille, France
⁴IRCCS Humanitas Research Hospital, Humanitas University, ROZZANO, ITA
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁷Pharma Research and Early Development, Innovation Center Welwyn, Roche, Welwyn, United Kingdom
⁸Innovation Center Welwyn, Roche, Welwyn, United Kingdom
⁹Pharma Research and Early Development, Roche Innovation Center Zurich, Roche, Schlieren, Switzerland
¹⁰Innovation Center Basel, Roche, Basel, Switzerland
¹¹Pharma Research and Early Development, Innovation Center Zürich, Roche, Zürich, Switzerland
¹²Pharma Research and Early Development, Roche Innovation Center Basel, Roche, Basel, Switzerland
¹³Product Development, Innovation Center Basel, Roche, Basel, Switzerland
¹⁴Product Development, Innovation Center Welwyn, Roche, Welwyn, United Kingdom
¹⁵Pharma Development, Innovation Center Basel, Roche, Basel, Switzerland
¹⁶Pharma Research and Early Development, Innovation Center Munich, Roche, Penzberg, Germany
¹⁷Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

Yun Kyoung Tiger, MD, PhD¹, Uma Atmuri^2* and Swami P. Iyer, MD³

¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²Acrotech Biopharma, East Windsor, NJ
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Jennifer E. Amengual, MD¹, Hongli Li, MS^2*, Patrick M. Reagan, MD³, Tareq Al Baghdadi, MD^4*, Hayder Saeed, MD⁵, Joseph M Unger, PhD^6*, Alexey Danilov, MD, PhD⁷, Michael Leblanc^2*, Jonathan W. Friedberg, MD⁸ and Sonali M. Smith, MD⁹

¹Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
²Fred Hutchinson Cancer Center, Seattle, WA
³University of Rochester School, Fairport, NY
⁴IHA Hematology Oncology Consultants, Ypsilanti, MI
⁵Moffitt Cancer Center, Tampa, FL
⁶Fred Hutchinson Cancer Research Center, Seattle
⁷City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA
⁸Wilmot Cancer Institute, University of Rochester, Rochester, NY
⁹University of Chicago, Chicago, IL

Koji Izutsu, MD, PhD¹, Noriko Fukuhara, MD, PhD², Makoto Sugaya^3*, Yuichi Baba^4*, Jin Hayakawa, MD^5*, Mitsufumi Nishio^4*, Alev Akyol, MD^6*, Akshay Sudhindra, MD⁶ and Kenji Ishitsuka, MD, PhD⁷

¹National Cancer Center Hospital, Tokyo, Japan
²Tohoku University Hospital, Miyagi, Japan
³4International University of Health and Welfare, Chiba, Japan
⁴Bristol Myers Squibb K.K., Tokyo, Japan
⁵Clinical development, Cell therapy and Hematology, Bristol Myers Squibb, Tokyo, Japan
⁶Bristol Myers Squibb, Princeton, NJ
⁷Kagoshima University Hospital, Kagoshima, Japan

Dipenkumar Modi, MD¹, Jay Yang, MD², Seongho Kim, PhD^3*, Asfar Azmi^4*, Emily Tolksdorf, BS^5*, Christiane A. Houde, BS^3* and Jeffrey A. Zonder, MD ⁶

¹Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
²Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
³Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁴Karmanos Cancer Institute/ Department of Oncology, Wayne State University, Detroit, MI
⁵Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁶Karmanos Cancer Institute, Detroit, MI